Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
67,722,533
-
Share change
-
+11,912,344
-
Total reported value
-
$1,143,897,781
-
Put/Call ratio
-
204%
-
Price per share
-
$16.89
-
Number of holders
-
121
-
Value change
-
+$208,583,662
-
Number of buys
-
70
-
Number of sells
-
54
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2024
As of 31 Mar 2024,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,722,533 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, Polar Capital Holdings Plc, GENDELL JEFFREY L, Vivo Capital, LLC, BRAIDWELL LP, WEALTH EFFECTS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, and CITADEL ADVISORS LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.